EC4 Part B

Hazard statements (CLP)

H315, H317, H319, H332, H335, H351, H373

Code

Statements

H315

Causes skin irritation

CLP CLASSIFICATION

d ~  GHS08 health hazard Carc. 2 H351 Suspected of causing cancer. STOT RE 2 H373 May cause damage to organs through prolonged or repeated exposure. d ~  GHS07 Acute Tox. 4 H332 Harmful if inhaled. Skin Irrit. 2 H315 Causes skin irritation. Eye Irrit. 2 H319 Causes serious eye irritation. Skin Sens. 1 H317 May cause an allergic skin reaction. STOT SE 3 H335 May cause respiratory irritation.

2.2 Label elements

Labelling according to Regulation (EC) No 1272/2008 The product is classified and labelled according to the CLP regulation.

Hazard pictograms

d ~  d ~  GHS07 GHS08

Hazardous Ingredients

oligomeres MDI

Hazard statements

H332 Harmful if inhaled. H315 Causes skin irritation. H319 Causes serious eye irritation. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H335 May cause respiratory irritation. H373 May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see on this label). P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

2.3 Other hazards

Persons with hypersensitivity of the airways (eg asthma, chronic bronchitis) may, with not handle the product. Symptoms in the respiratory tract can also still some hours occur after overexposure. Dust, vapors and aerosols are the primary threat to the Respiratory tract. The product does not contain any organic halogen compounds (AOX), nitrates, heavy metal compounds or formaldehydes.

PBT Substances

Not applicable

vPvB Substances

Not applicable